Skip to main content

Table 4 The ANCOVA results for comparing the neuropathic pain between the study groups in the second, third, and fourth assessment stages

From: Effectiveness of oral clonidine and gabapentin on peripheral neuropathy in diabetic patients in southwestern Iran: a randomized clinical trial

Index

stage

Source

SS

df

MS

F

P-value

Partial Eta Squared

Second assessment

Pre-test

338.48

1

338.48

65.63

< 0.001

0.71

Group

279.91

1

279.91

54.27

< 0.001

0.67

Error

139.26

27

5.16

   

Total

9829

30

    

Third assessment

Pre-test

125.26

1

125.26

12.09

0.002

0.31

Group

373.99

1

373.99

36.09

< 0.001

0.57

Error

279.81

27

10.36

   

Total

6050

30

    

Fourth assessment

Pre-test

116.83

1

116.83

11.49

0.002

0.30

Group

526.74

1

526.74

51.78

< 0.001

0.66

Error

274.63

27

10.17

   

Total

5003

30

    
  1. * Effect Size: A numerical value that determines the difference between data and a statistical hypothesis